Interactions Between Cranberry Juice and Antibiotics Used to Treat Urinary Tract Infections
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of study is to determine whether cranberry juice interacts with antibiotics used to treat urinary tract infections (UTIs).
| Condition | Intervention |
|---|---|
|
Urinary Tract Infections |
Drug: Cranberry juice Drug: Amoxicillin |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Pharmacokinetics Study Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Cranberry: Interactions With Anti-Infectious Agents |
- Drug Elmination
- Drug absorption
| Estimated Enrollment: | 18 |
| Study Start Date: | July 2006 |
| Estimated Study Completion Date: | June 2007 |
Although evidence of its effectiveness is limited, cranberry juice is widely used to prevent urinary tract infections (UTIs). However, recent studies have shown that cranberry juice may affect the way the body absorbs and metabolizes antibiotics used to treat UTIs. This study will determine whether concurrent cranberry juice administration lowers the urinary concentrations of two commonly used antibiotics, amoxicillin and cefaclor.
This study will involve children being treated for UTIs and adults without UTIs. All of the children will continue their prescribed amoxicillin/cefaclor treatment. After 7 to 10 days of antibiotic treatment, the children will be assigned to receive either cranberry juice for 2 days or no additional treatment. Urine samples will be collected from all child participants before and after the administration of cranberry juice to examine the excretion of the antibiotics.
Adult participants will receive two different doses of amoxicillin, with or without cranberry juice. Blood and urine samples will be collected to evaluate the effect of cranberry juice on the absorption and elimination of amoxicillin.
Eligibility| Ages Eligible for Study: | 6 Years to 50 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria for Children:
- Urinary tract infection (UTI) treated with cefaclor or amoxicillin
Inclusion Criteria for Adults:
- No UTI
Exclusion Criteria:
- Allergies to antibiotics
- Use of medications other than oral contraceptives
- Pregnancy or breast-feeding
- Smoker
Contacts and Locations
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00084201 History of Changes |
| Other Study ID Numbers: | R21 AT002077-01 |
| Study First Received: | June 8, 2004 |
| Last Updated: | November 28, 2006 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):
|
Vaccinium macrocarpon |
Additional relevant MeSH terms:
|
Urinary Tract Infections Infection Urologic Diseases Amoxicillin |
Anti-Bacterial Agents Anti-Infective Agents Therapeutic Uses Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 16, 2013